Display Settings:

Format

Send to:

Choose Destination

    Proc Natl Acad Sci U S A. 1988 Sep;85(18):6612-6.

    Human immunodeficiency virus has an aspartic-type protease that can be inhibited by pepstatin A.

    Seelmeier S, Schmidt H, Turk V, von der Helm K.

    Max von Pettenkofer Institute, University of Munich, Federal Republic of Germany.

    The protease encoded by the human immunodeficiency virus (HIV) processes the viral gag and gag-pol protein precursor by posttranslational cleavage. In this study we have demonstrated by site-specific mutagenesis (Asp----Thr) and by pepstatin A inhibition that the recombinant HIV protease is an aspartic-type protease. Furthermore, incubation of HIV-infected H9 cells with pepstatin A inhibited part of the intracellular processing of the HIV gag protein yet had no apparent toxicity on HIV-infected cells during 48 hr of incubation.

    PMID: 3045820 [PubMed - indexed for MEDLINE]

    PMCID: 282027

    Supplemental Content

    Click here to read Click here to read Click here to read Click here to read